Public Profile

ImmuneOncia Therapeutics, Inc.

ImmuneOncia Therapeutics, Inc., a pioneering biopharmaceutical company headquartered in South Korea (KR), is at the forefront of developing innovative immunotherapies for cancer treatment. Founded in 2015, the company has rapidly established itself within the biotechnology industry, focusing on the discovery and development of novel therapeutic agents that harness the body's immune system to combat malignancies. ImmuneOncia's core offerings include cutting-edge monoclonal antibodies and immune-modulating therapies, distinguished by their unique mechanisms of action and potential to improve patient outcomes. With a strong emphasis on research and development, the company has achieved significant milestones, including successful clinical trials that underscore its commitment to advancing cancer care. As a leader in the immuno-oncology sector, ImmuneOncia Therapeutics continues to make strides in transforming the landscape of cancer treatment.

DitchCarbon Score

How does ImmuneOncia Therapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

0

Industry Average

Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

0

Industry Benchmark

ImmuneOncia Therapeutics, Inc.'s score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

ImmuneOncia Therapeutics, Inc.'s reported carbon emissions

ImmuneOncia Therapeutics, Inc., headquartered in South Korea (KR), currently does not have available carbon emissions data for the most recent year, nor do they have specified reduction targets or climate pledges. As a result, there is no quantifiable information regarding their Scope 1, 2, or 3 emissions. In the absence of specific emissions data, it is important to note that many companies in the biopharmaceutical sector are increasingly focusing on sustainability and climate commitments. This often includes initiatives aimed at reducing their carbon footprint and enhancing environmental responsibility. ImmuneOncia Therapeutics may be engaging in similar efforts, although specific details are not provided. For stakeholders and environmentally conscious investors, it is crucial to monitor the company's future disclosures regarding emissions and climate strategies to assess their commitment to sustainability.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. ImmuneOncia Therapeutics, Inc.'s primary industry is , which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for ImmuneOncia Therapeutics, Inc. is in KR, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

ImmuneOncia Therapeutics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Byondis B.V.

NL
Research and development services (73)
Updated 1 day ago

Adagene Inc.

CN
Health and social work services (85)
Updated 1 day ago

Bristol Myers Squibb

AE
Retail trade services, except of motor vehicles and motorcycles; repair services of personal and household goods (52)
Updated 3 months ago
DitchCarbon Score

Jiangsu Chia Tai-Tianqing Pharmaceutical Co. Ltd

CN
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Conjupro Biotherapeutics Inc.

US
Updated 3 months ago
DitchCarbon Score

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers